Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome

Josephine M Y Ko1, Pui Ling Chan, Wing Lung Yau

  • 1Department of Biology, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, People's Republic of China.

Insights

Loss of chromosome 13q regions is common in esophageal squamous cell carcinoma (ESCC). Researchers identified thrombospondin type I domain-containing 1 (THSD1) as a key tumor suppressor gene, not RB1, in ESCC.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Loss of chromosome 13q regions is frequent in esophageal squamous cell carcinoma (ESCC).
  • Previous studies suggested chromosome 13 harbors tumor suppressor genes critical for ESCC.
  • Identifying specific tumor suppressor genes (TSGs) on 13q is crucial for understanding ESCC pathogenesis.

Purpose of the Study:

  • To identify novel tumor suppressor genes on chromosome 13q involved in esophageal squamous cell carcinoma.
  • To investigate the role of thrombospondin type I domain-containing 1 (THSD1) as a potential TSG in ESCC.
  • To elucidate the mechanisms of THSD1 silencing in ESCC.

Main Methods:

  • Monochromosome transfer into an ESCC cell line (SLMT-1) to identify tumor suppressor regions.
  • Differential gene expression profiling using cDNA microarrays.
  • Quantitative reverse transcription-PCR (qRT-PCR) to validate gene expression levels.
  • Analysis of loss of heterozygosity and promoter hypermethylation.
  • Functional assays involving transfection of THSD1 into ESCC cells.

Main Results:

  • Critical tumor suppressor regions on 13q were mapped to 13q12.3, 13q14.11, and 13q14.3.
  • Down-regulation of nine candidate 13q14 TSGs, including RB1, was observed in SLMT-1 cells.
  • Thrombospondin type I domain-containing 1 (THSD1) was identified as a novel candidate TSG, with its expression restored in tumor-suppressing hybrids.
  • THSD1 expression was down-regulated in 100% of tested ESCC and other cancer cell lines.
  • THSD1 silencing mechanisms included loss of heterozygosity and promoter hypermethylation.
  • Overexpression of THSD1 significantly reduced the colony-forming ability of SLMT-1 cells.

Conclusions:

  • THSD1, not RB1, is a strong candidate tumor suppressor gene in esophageal squamous cell carcinoma.
  • THSD1 plays a significant role in suppressing tumor growth and its silencing contributes to ESCC development.
  • THSD1 represents a potential therapeutic target for esophageal squamous cell carcinoma.